Sensory neuropathy hampers nociception-mediated bone marrow stem cell release in mice and patients with diabetes

Diabetologia

Volumn 58, Issue 11, 2015, Pages 2653-2662

  Dang, Zexu ^a   Maselli, Davide ^b   Spinetti, Gaia ^b   Sangalli, Elena ^b   Carnelli, Franco ^b   Rosa, Francesco ^b   Seganfreddo, Elena ^c   Canal, Fabio ^c   Furlan, Anna ^c   Paccagnella, Agostino ^d   Paiola, Emanuela ^b   Lorusso, Bruno ^e   Specchia, Claudia ^b,f   Albiero, Mattia ^g   Cappellari, Roberta ^g   Avogaro, Angelo ^g   Falco, Angela ^e   Quaini, Federico ^e   Ou, Kepeng ^a   Rodriguez Arabaolaza, Iker ^a   Emanueli, Costanza ^a   Sambataro, Maria ^d   Fadini, Gian Paolo ^g   Madeddu, Paolo ^a   more..

^a UNIVERSITY OF BRISTOL   (United Kingdom)

^b IRCCS MULTIMEDICA   (Italy)

^c CA FONCELLO HOSPITAL   (Italy)

^d Department of Specialized Medicines Endocrine Metabolic and Nutrition Diseases Unit Santa Maria of Ca Foncello Hospital   (Italy)

^e UNIVERSITY OF PARMA   (Italy)

^f UNIVERSITY OF BRESCIA   (Italy)

^g UNIVERSITY OF PADOVA   (Italy)

Author keywords

Bone marrow; Diabetes mellitus; Nociception

Indexed keywords

CD34 ANTIGEN; CD68 ANTIGEN; GRANULOCYTE COLONY STIMULATING FACTOR; NEUROKININ 1 RECEPTOR; SUBSTANCE P;

ANGIOGENESIS; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DIABETIC NEUROPATHY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLOW CYTOMETRY; HEMATOPOIETIC STEM CELL; HUMAN; IMMUNOHISTOCHEMISTRY; LIMB ISCHEMIA; MALE; MORPHOMETRICS; MOUSE; NOCICEPTION; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; SENSORY NEUROPATHY; STEM CELL MOBILIZATION; TISSUE REPAIR; ANIMAL; COMPLICATION; EXPERIMENTAL DIABETES MELLITUS; METABOLISM; PATHOLOGY; PHYSIOLOGY; SENSORY NERVE CELL;

ANIMALS; CROSS-SECTIONAL STUDIES; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; HEMATOPOIETIC STEM CELLS; HUMANS; MICE; NOCICEPTION; SENSORY RECEPTOR CELLS; SUBSTANCE P;

EID: 84942988696     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-015-3735-0     Document Type: Article

References (29)

1. DiPersio JF (2011) Diabetic stem-cell "mobilopathy". N Engl J Med 365:2536–2538
2. Fadini GP, Albiero M, Vigili de Kreutzenberg S et al (2013) Diabetes impairs stem cell and proangiogenic cell mobilization in humans. Diabetes Care 36:943–949
3. Fadini GP, Ferraro F, Quaini F, Asahara T, Madeddu P (2014) Concise review: diabetes, the bone marrow niche, and impaired vascular regeneration. Stem Cells Transl Med 3:949–957
4. Amadesi S, Reni C, Katare R, et al (2012) Role for substance p-based nociceptive signaling in progenitor cell activation and angiogenesis during ischemia in mice and in human subjects. Circulation 125:1774-1786, S1771-S1719
5. Ismail-Beigi F, Craven T, Banerji MA et al (2010) Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial. Lancet 376:419–430
6. Pop-Busui R, Evans GW, Gerstein HC et al (2010) Effects of cardiac autonomic dysfunction on mortality risk in the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial. Diabetes Care 33:1578–1584
7. Anand P, Terenghi G, Warner G, Kopelman P, Williams-Chestnut RE, Sinicropi DV (1996) The role of endogenous nerve growth factor in human diabetic neuropathy. Nat Med 2:703–707
8. Anand P (2004) Neurotrophic factors and their receptors in human sensory neuropathies. Prog Brain Res 146:477–492
9. Boulton AJ, Vinik AI, Arezzo JC et al (2005) Diabetic neuropathies: a statement by the American Diabetes Association. Diabetes Care 28:956–962
10. Reinisch CM, Traxler H, Piringer S, Tangl S, Nader A, Tschachler E (2008) Rarefaction of the peripheral nerve network in diabetic patients is associated with a pronounced reduction of terminal Schwann cells. Diabetes Care 31:1219–1221
11. Pittenger GL, Ray M, Burcus NI, McNulty P, Basta B, Vinik AI (2004) Intraepidermal nerve fibers are indicators of small-fiber neuropathy in both diabetic and nondiabetic patients. Diabetes Care 27:1974–1979
12. Lennertz RC, Medler KA, Bain JL, Wright DE, Stucky CL (2011) Impaired sensory nerve function and axon morphology in mice with diabetic neuropathy. J Neurophysiol 106:905–914
13. Lucas D, Bruns I, Battista M et al (2012) Norepinephrine reuptake inhibition promotes mobilization in mice: potential impact to rescue low stem cell yields. Blood 119:3962–3965
14. Katayama Y, Battista M, Kao WM et al (2006) Signals from the sympathetic nervous system regulate hematopoietic stem cell egress from bone marrow. Cell 124:407–421
15. Feldman EL, Stevens MJ, Thomas PK, Brown MB, Canal N, Greene DA (1994) A practical two-step quantitative clinical and electrophysiological assessment for the diagnosis and staging of diabetic neuropathy. Diabetes Care 17:1281–1289
16. Vinik AI, Erbas T (2013) Diabetic autonomic neuropathy. Handb Clin Neurol 117:279–294
17. The Consensus Committee of the American Autonomic Society and the American Academy of Neurology (1996) Consensus statement on the definition of orthostatic hypotension, pure autonomic failure, and multiple system atrophy. Neurology 46:1470
18. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG (2007) Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg 45 (Suppl S):S5-S67
19. van Der Auwera P, Platzer E, Xu ZX et al (2001) Pharmacodynamics and pharmacokinetics of single doses of subcutaneous pegylated human G-CSF mutant (Ro 25-8315) in healthy volunteers: comparison with single and multiple daily doses of filgrastim. Am J Hematol 66:245–251
20. Albiero M, Poncina N, Tjwa M et al (2014) Diabetes causes bone marrow autonomic neuropathy and impairs stem cell mobilization via dysregulated p66Shc and Sirt1. Diabetes 63:1353–1365
21. Muller KA, Ryals JM, Feldman EL, Wright DE (2008) Abnormal muscle spindle innervation and large-fiber neuropathy in diabetic mice. Diabetes 57:1693–1701
22. Madeddu P, Emanueli C, Spillmann F et al (2006) Murine models of myocardial and limb ischemia: diagnostic end-points and relevance to clinical problems. Vasc Pharmacol 45:281–301
23. Katare RG, Caporali A, Oikawa A, Meloni M, Emanueli C, Madeddu P (2010) Vitamin B1 analog benfotiamine prevents diabetes-induced diastolic dysfunction and heart failure through Akt/Pim-1-mediated survival pathway. Circ Heart Fail 3:294–305
24. Spinetti G, Cordella D, Fortunato O et al (2013) Global remodeling of the vascular stem cell niche in bone marrow of diabetic patients: implication of the microRNA-155/FOXO3a signaling pathway. Circ Res 112:510–522
25. Ferraro F, Lymperi S, Mendez-Ferrer S et al (2011) Diabetes impairs hematopoietic stem cell mobilization by altering niche function. Sci Transl Med 3:104ra101
26. Busik JV, Tikhonenko M, Bhatwadekar A et al (2009) Diabetic retinopathy is associated with bone marrow neuropathy and a depressed peripheral clock. J Exp Med 206:2897–2906
27. Mirotsou M, Jayawardena TM, Schmeckpeper J, Gnecchi M, Dzau VJ (2011) Paracrine mechanisms of stem cell reparative and regenerative actions in the heart. J Mol Cell Cardiol 50:280–289
28. Albiero M, Avogaro A, Fadini GP (2013) Restoring stem cell mobilization to promote vascular repair in diabetes. Vasc Pharmacol 58:253–258
29. Fiorina P, Pietramaggiori G, Scherer SS et al (2010) The mobilization and effect of endogenous bone marrow progenitor cells in diabetic wound healing. Cell Transplant 19:1369–1381